Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Experimental and Clinical Psychopharmacology
|
May 23, 2002
Conditioning history and the reinforcing effects of drugs: comment on Alessi, Roll, Reilly, and Johanson (2002)
Thomas H Kelly
Drug and Alcohol Dependence
|
June 17, 2016
Emotion regulation and drug abuse: Implications for prevention and treatment
Thomas H Kelly, Michael T Bardo
Journal of Sport Rehabilitation
|
December 1, 2010
Training and career development in clinical and translational science: an opportunity for rehabilitation scientists
Thomas H Kelly, Carl G Mattacola
Drug and Alcohol Dependence
|
January 14, 2011
Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Clinical Neuropharmacology
|
September 15, 2010
Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol
Joshua A Lile, Thomas H Kelly, Lon R Hays
Drug and Alcohol Dependence
|
June 16, 2012
Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Drug and Alcohol Dependence
|
October 7, 2011
Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Drug and Alcohol Dependence
|
January 25, 2005
Effects of d-amphetamine in human models of information processing and inhibitory control
Mark T Fillmore, Thomas H Kelly, Catherine A Martin
Drug and Alcohol Dependence
|
August 16, 2014
Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Behavioural Pharmacology
|
December 2, 2009
The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users
Joshua A Lile, Thomas H Kelly, Lon R Hays
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Experimental and Clinical Psychopharmacology
|
May 23, 2002
Conditioning history and the reinforcing effects of drugs: comment on Alessi, Roll, Reilly, and Johanson (2002)
Thomas H Kelly
Drug and Alcohol Dependence
|
June 17, 2016
Emotion regulation and drug abuse: Implications for prevention and treatment
Thomas H Kelly, Michael T Bardo
Journal of Sport Rehabilitation
|
December 1, 2010
Training and career development in clinical and translational science: an opportunity for rehabilitation scientists
Thomas H Kelly, Carl G Mattacola
Drug and Alcohol Dependence
|
January 14, 2011
Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Clinical Neuropharmacology
|
September 15, 2010
Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol
Joshua A Lile, Thomas H Kelly, Lon R Hays
Drug and Alcohol Dependence
|
June 16, 2012
Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Drug and Alcohol Dependence
|
October 7, 2011
Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Drug and Alcohol Dependence
|
January 25, 2005
Effects of d-amphetamine in human models of information processing and inhibitory control
Mark T Fillmore, Thomas H Kelly, Catherine A Martin
Drug and Alcohol Dependence
|
August 16, 2014
Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC
Joshua A Lile, Thomas H Kelly, Lon R Hays
Behavioural Pharmacology
|
December 2, 2009
The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users
Joshua A Lile, Thomas H Kelly, Lon R Hays
Page
of 7